Hybridizing biofabrication processes will lead us to superior “living” tissue and organ substitutes that can be used to treat patients in lieu of donor grafts and metal and plastic devices.
Nanotechnology is poised to revolutionize the diagnosis and treatment of patients with type 1 diabetes.
A new study explores how metal nanoparticles designed for new X-ray imaging technologies can improve the diagnosis of diseases, as well as understand the underlying cellular processes.
Cutting-edge fluorine-19 imaging of inflammation extends the frontiers of MRI.
Micro- and nanoparticle-based drug delivery systems are revolutionizing medicine, from minimizing the toxicity of therapeutics to improving their efficacy.
Researchers at Houston Methodist Research Institute discuss how quantitative, non-invasive imaging can aid in developing novel tools for diagnosis and therapy.
Antibiotic-resistant bacteria are becoming a major global threat. Novel antibacterial nanomaterials offer a solution.
A nanocarrier that can deliver siRNA into the lungs is investigated for the treatment of severe asthma and other lung diseases.
The Lahann Lab at the University of Michigan discusses how nanomedicine benefits by bridging biology, engineering, and materials.
Exploring advances in extracellular vesicles research made in the last ten-years and how its leading to better clinical applications.